| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |